Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio.

Paracchini V, Pedotti P, Raimondi S, Garte S, Bradlow HL, Sepkovic DW, Taioli E.

Clin Chem Lab Med. 2005;43(7):702-6.

PMID:
16207128
2.

CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal.

Sowers MR, Wilson AL, Kardia SR, Chu J, McConnell DS.

Am J Med. 2006 Sep;119(9 Suppl 1):S44-51.

PMID:
16949388
3.

Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk.

Taioli E, Bradlow HL, Garbers SV, Sepkovic DW, Osborne MP, Trachman J, Ganguly S, Garte SJ.

Cancer Detect Prev. 1999;23(3):232-7.

PMID:
10337002
4.

Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.

Greenlee H, Chen Y, Kabat GC, Wang Q, Kibriya MG, Gurvich I, Sepkovic DW, Bradlow HL, Senie RT, Santella RM, Ahsan H.

Breast Cancer Res Treat. 2007 Mar;102(1):111-7. Epub 2006 Jul 19.

PMID:
16850246
5.

Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.

Bailey LR, Roodi N, Dupont WD, Parl FF.

Cancer Res. 1998 Nov 15;58(22):5038-41. Erratum in: Cancer Res 1999 Mar 15;59(6):1388.

6.

The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.

Napoli N, Rini GB, Serber D, Giri T, Yarramaneni J, Bucchieri S, Camarda L, Di Fede G, Camarda MR, Jain S, Mumm S, Armamento-Villareal R.

Bone. 2009 Mar;44(3):442-8. doi: 10.1016/j.bone.2008.09.018. Epub 2008 Oct 15.

7.

CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.

Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG.

Carcinogenesis. 2005 Dec;26(12):2207-12. Epub 2005 Jul 28.

PMID:
16051642
8.

Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls.

Tang YM, Green BL, Chen GF, Thompson PA, Lang NP, Shinde A, Lin DX, Tan W, Lyn-Cook BD, Hammons GJ, Kadlubar FF.

Pharmacogenetics. 2000 Dec;10(9):761-6.

PMID:
11221602
9.

Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.

Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG.

Lung Cancer. 2007 Mar;55(3):255-62. Epub 2006 Dec 15.

10.

Changes in 2-hydroxyestrone and 16alpha-hydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype.

McCann SE, Wactawski-Wende J, Kufel K, Olson J, Ovando B, Kadlubar SN, Davis W, Carter L, Muti P, Shields PG, Freudenheim JL.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):256-62.

11.

CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.

Sillanpää P, Heikinheimo L, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Metsola K, Hirvonen A.

Breast Cancer Res Treat. 2007 Sep;104(3):287-97. Epub 2006 Oct 25.

PMID:
17063266
12.
13.
14.

Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.

Ursin G, London S, Yang D, Tseng CC, Pike MC, Bernstein L, Stanczyk FZ, Gentzschein E.

Breast Cancer Res Treat. 2002 Mar;72(2):139-43.

PMID:
12038704
15.

Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.

Wang Q, Li H, Tao P, Wang YP, Yuan P, Yang CX, Li JY, Yang F, Lee H, Huang Y.

DNA Cell Biol. 2011 Aug;30(8):585-95. doi: 10.1089/dna.2010.1195. Epub 2011 Mar 27.

PMID:
21438753
16.
17.

Interaction between genetic polymorphism of cytochrome P450-1B1 and environmental pollutants in breast cancer risk.

Saintot M, Malaveille C, Hautefeuille A, Gerber M.

Eur J Cancer Prev. 2004 Feb;13(1):83-6.

PMID:
15075793
18.

A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC.

Environ Health Perspect. 1997 Apr;105 Suppl 3:601-5.

19.

Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.

Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC.

J Natl Cancer Inst. 1999 Jun 16;91(12):1067-72.

PMID:
10379970
20.

Supplemental Content

Support Center